Ki-67: A useful marker for the evaluation of dysplasia in ulcerative colitis

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 6, 1998, Pages 327-332

  Andersen, S N ^a   Rognum, T O ^a   Bakka, A ^b   Clausen, O P F ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

Dysplasia; Ki 67 immunohistochemistry; Ulcerative colitis

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON RESECTION; EPITHELIUM DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0032443328     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.6.327     Document Type: Article

References (35)

1. Morson BD, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
2. Lennard-Jones JE, Morson BC, Ritchie JK, et al. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977;73:1280-9.
3. Lennard-Jones JE, Melville DM, Morson BC, et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800-6.
4. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29: 206-17.
5. Sugita A, Sachar DB, Bodian C, et al. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis cancer interval. Gut 1991;32:167-9.
6. Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14: 931-68.
7. Paganelli GM, Lalli E, Facchini A, et al. Flow cytometric and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer. Am J Gastroenterol 1994;89:220-4.
8. Matthew JA, Pell JD, Prior A, et al. Validation of a simple technique for the detection of abnormal mucosal cell replication in humans. Eur J Cancer Prev 1994;3:337-44.
9. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
10. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed parafin sections. J Pathol 1992;168:557-63.
11. McCormick D, Chong H, Hobbs C, et al. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1. Histopathology 1993;22:355-60.
12. Holt PR, Moss SF, Kapetanakis AM, et al. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Cancer Epidemiol Biomarkers Prev 1997;6: 131-5.
13. Shepherd NA, Richman PI, England J. Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol 1988;155:213-19.
14. Hoang C, Polivka M, Valleur P, et al. Immunohistochemical detection of proliferating cells in colorectal carcinomas and adenomas with the monoclonal antibody Ki-67. Preliminary data. Virchows Arch 1989;414:423-8.
15. Johnston PG, O'Brien MJ, Dervan PA, et al. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum Pathol 1989;20:696-700.
16. Kubota Y, Petras RE, Easly KA, et al. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer 1992;70:2602-9.
17. Suzuki H, Matsumoto K, Terabe M. Ki-67 antibody labeling index in colorectal carcinoma. J Clin Gastroenterol 1992;15:317-20.
18. Kullmann F, Fadaie M, Gross V, et al. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:371-9.
19. Noffsinger AE, Miller MA, Cusi MV, et al. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer 1996;78:2307-12.
20. Stave R, Brandtzaeg P. Fluorescence staining of gastric mucosa. A study with special reference to parietal cells. Scand J Gastroenterol 1977;12:885-91.
21. SAS Institute Inc. SAS STAT software: changes and enhancements through release 6, 11. Cary, NC: SAS Institute Inc, 1996.
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
23. Deschner EE. Early proliferative changes in gastrointestinal neoplasia. Am J Gastroenterol 1982;77:207-11.
24. Lipkin M. Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer 1974;34:878-88.
25. Deschner EE, Winawer SJ, Katz S, et al. Proliferative defects in ulcerative colitis patients. Cancer Invest 1983;1:41-7.
26. Biasco G, Paganelli GM, Miglioli M, et al. Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res 1990;50:1156-9.
27. Alpers DH, Philpott G, Grimme NL, et al. Control of thymidine incorporation in mucosal explants from patients with chronic ulcerative colitis. Gastroenterology 1980;78: 470-8.
28. Risio M, Lipkin M, Candelaresi GL, et al. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res 1991;51:1917-21.
29. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133: 1710-15.
30. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992;25:31-40.
31. Scott RJ, Hall PA, Haldane JS, et al. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 1991; 165:173-8.
32. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
33. Burmer GC, Levine DS, Kulander BG, et al. C-ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990;99:416-20.
34. Greenwald BD, Harpaz N, Yin J, et al. Loss of heterozygosity affecting the p53, Rb, and mcc apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992;52:741-5.
35. Kern SE, Redston M, Seymour AB, et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994;107:420-8.